Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

NCT06128447 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Soil-Transmitted Helminthiasis (STH)

Interventions

DRUG: ZP5-9676 600 mg dose
DRUG: Placebo

Sponsor

Zero Point Five Therapeutics